Fitwithliz shares a day of eating on Wegovy after dropping 50 lbs
Liz cooks her meals for the day, runs through her skincare and catches viewers up on life 50 lbs into Wegovy.
Recap by typeshit. Full story at Fitwithliz.
Watch on YouTube
More peptides
-
Experimental injection that makes fat cells self destruct shows early promise 
Experimental injection that makes fat cells self destruct shows early promise
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
-
Mochi Health cuts prices on compounded semaglutide and tirzepatide 
Mochi Health cuts prices on compounded semaglutide and tirzepatide
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
-
Andrew Huberman on certified USA made peptides and verified standards 
Andrew Huberman on certified USA made peptides and verified standards
Huberman says verified, US-made sourcing would change the peptide market, and wonders which compounds beyond GLPs would qualify.
-
IOHA explains why burning stored body fat is harder than it seems IOHA explains why burning stored body fat is harder than it seems
A general explainer on why the body holds onto its large fat reserves even though they carry tens of thousands of calories.
-
Samuel Hume lists three big psoriasis drug advances, including tirzepatide Samuel Hume lists three big psoriasis drug advances, including tirzepatide
Icotrokinra became the first approved oral IL23 receptor blocker, and a trial found tirzepatide plus ixekizumab gave deeper responses.
-
Oral Wegovy scripts dip 3.3% while Zepbound keeps a wide lead over Novo Oral Wegovy scripts dip 3.3% while Zepbound keeps a wide lead over Novo
Oral Wegovy fell to about 173,500 weekly prescriptions and Foundayo rose to 60,151. Novo also eyes 15 to 20% yearly GLP-1 growth in India.
